Gilead's FOCUS Program Helps Zero In on Early HIV Detection [Yahoo! Finance]
Gilead Sciences, Inc. (GILD)
Last gilead sciences, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.gilead.com
Company Research
Source: Yahoo! Finance
But when his symptoms worsened, he returned to the emergency department and was given a more thorough check-up and routine screening exams - including an HIV test - based on the facility's screening eligibility criteria. When the test came back positive, the student was immediately linked to care and he became one of the many people whose lives have been impacted by Gilead's FOCUS program. Launched in 2010, FOCUS enables partners to develop and share best practices in screenings and diagnosis of HIV, hepatitis B and C, as well as linkage to care, in accordance with public health guidelines. "It probably would have been some time for someone to say, ‘Let's test this patient for HIV,'" says registered nurse Melissa Mollere of Ochsner Health System. "There was no reason to suspect anything otherwise. When FOCUS first launched in Baton Rouge in 2016, the city had the highest number of late-stage HIV diagnoses of any city in the country. With FOCUS partnerships in place, the number o
Show less
Read more
Impact Snapshot
Event Time:
GILD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GILD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GILD alerts
High impacting Gilead Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
GILD
News
- Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis [Yahoo! Finance]Yahoo! Finance
- Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary CholangitisBusiness Wire
- Kite Data at EHA 2024 Demonstrate Positive Patient Outcomes and Advances in Delivery of CAR T-cell TherapyBusiness Wire
- ABMRF Invests in Amygdala Neurosciences to Develop ANS-858 for Alcohol Use Disorder [Yahoo! Finance]Yahoo! Finance
- One stock is dragging down the S&P 500's earnings growth [Yahoo! Finance Canada]Yahoo! Finance Canada
GILD
Earnings
- 4/25/24 - Beat
GILD
Sec Filings
- 5/9/24 - Form 4
- 5/9/24 - Form 4
- 5/9/24 - Form 4
- GILD's page on the SEC website